You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
遠大醫藥(00512.HK)對醫藥基金進行投資
阿思達克 06-22 18:03
遠大醫藥(00512.HK)公布,旗下全資擁有附屬公司宏力與普通合夥人訂立認購協議,對一個基金進行投資,擬作出的資本承諾為5,000萬美元(相等約3.9億港元)。基金計劃募集共2億美元。

普通合夥人由東海資本持有50%。東海資本為上海產融之全資擁有附屬公司,而上海產融由公司之其中一名控股股東胡先生全資擁有的北京遠大持有70%。因此,普通合夥人為公司的控股股東之聯繫人士,並因此為公司之關連人士。

目前集團正在加速投資創新性技術和產品,在全球範圍內尋找優質研發項目擴充集團的研發管線和提高本集團的研發實力,大力向創新和國際化進行轉型。基金的投資範圍和領域與集團發展目標高度契合,即主要包括投資世界領先的醫藥公司及醫藥器械生產商,主要集中於生物制藥、心血管、眼科、腫瘤治療等領域。

因此,對基金作出投資為符合集團之業務策略,不僅有助於分擔集團對此類投資的研發和財務風險,同時有助於集團在同等投資金額的情況下進一步擴大對創新項目孵化和培育的範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account